Tumor DNA synthesis and replication machinery

The term "Tumor DNA synthesis/replication machinery" does not refer to a single molecule or receptor but rather encompasses a collection of enzymes and protein complexes responsible for copying cellular genetic material during cell division. In cancer cells, this machinery is often dysregulated due to mutations in genes controlling the cell cycle and checkpoints. Key elements include **DNA polymerases**, **helicases**, **topoisomerases**, and regulatory proteins such as **cyclins** and **cyclin-dependent kinases**. Mutations affecting these pathways can lead to uncontrolled proliferation—a hallmark of cancer[2]. Therapeutic strategies often target specific components within this system rather than the entire "machinery," using agents like topoisomerase inhibitors or CDK inhibitors. Because this entry refers broadly to an entire process/system rather than a discrete molecular target, it is considered incorrect as a canonical therapeutic target name[2]. If you need structured information about any specific enzyme or protein complex within tumor DNA synthesis/replication pathways—such as "Topoisomerase II alpha" or "Cyclin-dependent kinase 4"—please specify that particular molecule for more precise data.

Other names

DNA replication machinery in cancerCell cycle control machinery in tumorsTumor cell DNA synthesis apparatus